https://www.selleckchem.com/pr....oducts/Obatoclax-Mes
155; p = 0.002; CI 1.535-6.487). Additional outcomes analyzed wereneed for vasopressors, presence ofshock, and acute kidney injury. Patients with diarrhea were 2.738 (p = 0.007; CI 1.325-5.658), 2.467 (p = 0.013; CI 1.209-5.035), and 2.694 (p = 0.007; CI 1.305-5.561)times more likely to experiencethese outcomes, respectively. Screening questions should be expanded to include common GI symptomsin patients with COVID-19. Health care providers should note whether their patient is presenting with diarrhea due to the potential imp
Like
Comment
Share
